ArticleCureus2026
Bleb Revision Using an L-shaped Conjunctival Flap Posterior to the Limbus in Eyes With Bleb Failure After PreserFlo MicroShunt Implantation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bleb fibrosis is a major cause of early surgical failure after PreserFlo MicroShunt implantation. Although needling is commonly attempted as first-line management, its effectiveness may be limited in cases with dense Tenon's encapsulation. The optimal surgical approach for open revision has not been well defined. This case series presents four consecutive eyes with bleb failure after PreserFlo MicroShunt implantation treated with revision using a fornix-based L-shaped conjunctival flap posterior to the limbus technique. Intraocular pressure (IOP), best-corrected visual acuity, corneal endothelial cell density, complications, and need for additional interventions were evaluated. The mean IOP decreased from 30.4 mmHg preoperatively to 9.5 mmHg at one month, 10.8 mmHg at three months, 12.5 mmHg at six months, and 13.4 mmHg at one year postoperatively. Visual acuity remained stable, and no clinically significant endothelial cell loss was observed. One transient choroidal detachment resolved spontaneously. One case required adjunctive topical glaucoma medication during follow-up; however, no patient required additional surgical intervention. Bleb revision using this posterior conjunctival flap technique effectively restored filtration and achieved sustained IOP reduction in eyes with bleb failure after PreserFlo MicroShunt implantation. By avoiding conjunctival dissection directly over the implant and minimizing limbal manipulation, this flow-redirection technique may preserve conjunctival integrity and represent a rational surgical alternative in selected cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.